Mr. Ainsworth brings over two decades of industry and market access experience to Tonix U.S. Food and Drug Administration ...

A new dad has revealed how an ongoing headache turned out to be terminal brain cancer and he is unsure how much time he has ...

Several large drugmakers, including Pfizer, Bristol Myers Squibb and Sanofi, increased the list prices of their drugs this ...

NEW YORK CITY, New York: At the start of 2025, drug companies raised prices on over 250 brand-name medications in the U.S., including Pfizer's COVID-19 treatment Paxlovid, Bristol Myers Squibb's ...

Pharmaceutical companies are raising the price of over 250 brand drugs this year. Nearly all the price increases are under 10 ...

While the New Year's tradition of drug price hikes has held firm for years, pharma companies have decidedly tamped down on ...

Pfizer has raised the price of Paxlovid, the anti-COVID medicine, by 3 per cent, the migraine treatment, Nurtec, and cancer ...

More than 250 medications, including Paxlovid and cancer therapies, will see price increases in the United States beginning ...

The increases are to list prices, which do not include rebates to pharmacy benefit managers and other discounts.

Several major pharmaceutical companies, including Pfizer, Bristol Myers Squibb and Sanofi, are set to raise prices on more than 250 branded medications in the U.S. starting Jan. 1, 2025, according to ...

Drugmakers plan to raise U.S. prices on at least 250 branded medications including Pfizer COVID-19 treatment Paxlovid, ...

Pfizer raised prices of the most drugs on the latest list — more than 60 drugs. As well as a 3 percent hike on Paxlovid, the company raised prices on medicines including migraine treatment Nurtec and ...